Pay vs Performance Disclosure, Table

PAY VERSUS PERFORMANCE

As highlighted in “Compensation Discussion and Analysis,” one of the primary principles of our compensation program is to ensure that there is a substantial portion of executive officer pay that is

at-risk

and highly dependent on Cadence’s short-term and long-term financial, operational, and stock price performance.

For our executives, over 80% of their opportunity is tied to long-term equity incentives that depend on our stock price performance, while roughly 5% to 10% of our executive pay is tied to annual financial and operational performance. As a result, we would expect that our Compensation Actually Paid in the table below will have a stronger correlation with our TSR and stock price performance than our annual financial and operational performance. We expect a strong correlation to stock price performance through the combination of (a) having a significant portion of executive pay tied to long-term incentives and (b) the granting of periodic LTP awards that require meeting material stock price growth hurdles before any value is delivered to our executives, and the historical use of options in our annual long-term incentives mix prior to 2025 (50% for our CEO and 34% for our other NEOs).

In the charts and descriptions of the relationships presented below we note the following:

(a)

We show two Principal Executive Officers (“PEOs”) over the five-year period due to our CEO transition in 2021 (Dr. Devgan is PEO #1 for all five years and Mr. Tan is PEO #2 for 2021).

(b)

As stated above, our Compensation Actually Paid may vary notably year-over-year. These swings occur primarily due to: (a) the Compensation Actually Paid calculation measuring the change in fair value of equity awards (not the absolute value), (b) the stock price performance differing meaningfully in certain years, and (c) our practice of granting periodic LTP awards with challenging stock price hurdles and options prior to 2025.

For example, the large increase in Compensation Actually Paid for 2023 compared to 2022 was a result of our stock price growing 70% in 2023 versus decreasing 14% in 2022. Additionally, the stock price increased to be above the LTP III price hurdles, leading to higher values vesting in March 2023 and March 2024. Further, the notable decrease in Compensation Actually Paid in 2024 reflects a relatively modest stock price increase of 10% (versus 70% for 2023), with the stock price being below the maximum price target for LTP IV awards and only slightly above the exercise price for options awarded in 2024. For 2025, the larger increase to Compensation Actually Paid again was driven primarily by our practice of periodically granting LTP awards.

These observed year-over-year changes in our Compensation Actually Paid demonstrate the strong alignment between our long-term equity incentives and stock price performance. As such, we would expect larger Compensation Actually Paid values in years with stronger stock price performance and smaller values in years with lower performance.

The following table sets forth additional compensation information of our PEO and our other

(non-PEO)

NEOs along with TSR, net income, and

non-GAAP

operating income performance results for our fiscal years 2021, 2022, 2023, 2024, and 2025.



																				Value of Initial Fixed $100 Investment Based On:
Year (1)		Summary Comp Table Total for PEO#1 (2)			Compensation Actually Paid to PEO#1 (3)(4)			Summary Comp Table Total for PEO#2 (2)			Compensation Actually Paid to PEO#2 (3)(5)			Average Summary Comp Table Total for non-PEO NEOs (2)			Average Compensation Actually Paid to non-PEO NEOs (3)(6)			Cadence Design Systems’ Total Shareholder Return (7)		Peer Group Total Shareholder Return (7)		GAAP Net Income			Non-GAAP Operating Income (8)
(a)		(b)			(c)			(b)			(c)			(d)			(e)			(f)		(g)		(h)			(i)

	2025		$	56,547,667		$	95,274,525			N/A			N/A		$	15,806,397		$	24,629,815		$229		$258		$	1,108,888,000		$	2,361,000,000

	2024		$	19,292,503		$	28,687,892			N/A			N/A		$	5,477,021		$	7,966,742		$220		$208		$	1,055,484,000		$	1,974,360,000

	2023		$	17,341,862		$	119,135,192			N/A			N/A		$	5,291,144		$	34,337,386		$200		$152		$	1,041,144,000		$	1,717,212,000

	2022		$	32,216,034		$	24,757,155			N/A			N/A		$	10,293,930		$	7,377,865		$118		$97		$	848,952,000		$	1,436,357,000

	2021		$	21,735,794		$	39,820,493		$	11,166,016		$	60,351,290		$	5,188,515		$	14,539,214		$137		$135		$	695,955,000		$	1,110,755,000

(1)	NEOs included in the above compensation columns reflect the following:


Year	PEO #1	PEO #2	Non-PEO NEOs
2025	Dr. Devgan	—	Messrs. Wall, Cunningham, Teng and Scannell
2024 2023	Dr. Devgan Dr. Devgan	— —	Messrs. Wall, Beckley, Cunningham, Teng and Scannell Messrs. Wall, Zaman, Cunningham and Teng
2022	Dr. Devgan	—	Messrs. Wall, Zaman, Cunningham and Teng
2021	Dr. Devgan	Mr. Tan	Messrs. Wall, Zaman, Teng and Beckley

(2)

Amounts reported in this column represent (i) the total compensation as reported in the Summary Compensation Table for the applicable year in the case of Dr. Devgan and Mr. Tan (for each year they served as PEO) and (ii) the average of the total compensation as reported in the Summary Compensation Table for Cadence’s other NEOs for the applicable year.

(3)

The fair value or change in fair value, as applicable, of equity awards in the “Compensation Actually Paid” columns has been estimated pursuant to the guidance in Accounting Standards Codification Topic No. 718: Compensation–Stock Compensation (“ASC Topic 718”). The fair values of restricted share awards that are subject to solely service-based vesting criteria equals the closing price on applicable

year-end

date(s) or, in the case of vesting dates, the closing price on the applicable vesting dates. The fair values of LTP awards that vest upon the attainment of both stock price targets and TSR hurdles relative to a group of peer companies were estimated with a Monte Carlo simulation model as of the applicable

year-end

date(s) using the same methodology as used to estimate the grant date fair value, but using each company’s closing stock price on the applicable revaluation date as the current market price and volatility assumptions and risk free rates determined as of the revaluation date based on the length of the LTP award’s remaining performance measurement period. The vest date values of the LTP awards equals the closing price on the applicable vesting dates. The fair values of stock options were estimated using the Black Scholes option pricing model as of the applicable

year-end

or vesting date(s), using the same methodology as used to estimate the grant date fair value but using (a) the closing stock price on applicable revaluation date as the current market price, (b) an expected remaining life assumption that is based on the stock options remaining contractual term as the applicable revaluation date and the degree to which the revaluation date stock price is greater than or less than the exercise price, with stock options that have an exercise price that is less than the revaluation date stock price having a shorter remaining expected life and stock options that have an exercise price that is greater than the revaluation date stock price having a longer remaining expected life, (c) expected volatility assumptions and risk free rates determined as of the revaluation date based on the length of the expected remaining life, and (d) an expected dividend rate of 0%. For additional information on the assumptions used to estimate the fair value of the awards, see the Notes to Consolidated Financial Statements in Cadence’s Annual Reports on Form

10-K

for the fiscal year ended December 31, 2025 and prior fiscal years.

(4)	Compensation Actually Paid to PEO #1 (Dr. Devgan) reflects the following adjustments from Total compensation reported in the Summary Compensation Table:


	2025				2024				2023				2022				2021
Total Reported in Summary Compensation Table (SCT)		$	56,547,667			$	19,292,503			$	17,341,862			$	32,216,034			$	21,735,794

Less, value of Stock Awards reported in SCT		($	54,412,532	)		($	17,351,77	)		($	15,392,704	)		($	30,098,15	)		($	19,996,36	)
Plus, Year-End value of Awards Granted in Fiscal Year that are Unvested and Outstanding		$	79,730,095			$	15,440,701			$	20,512,907			$	33,730,111			$	20,926,797
Plus, Change in Fair Value (from prior year-end to indicated year-end) of Prior Years awards that are Outstanding and Unvested		$	9,473,706			$	6,094,969			$	65,834,172			($	31,069,49	)		($	4,318,614	)
Plus, FMV of Awards Granted and Vested in the indicated Year		$	0			$	1,326,066			$	1,733,185			$	962,229			$	557,207
Plus, Change in Fair Value (from prior year-end to vesting date) of Prior Year awards that Vested this year		$	3,935,589			$	3,885,430			$	29,105,769			$	19,016,429			$	20,915,668
Less Prior Year Fair Value of Prior Year awards that Failed to vest this year		($	0	)		($	0	)		($	0	)		($	0	)		($	0	)

Total Adjustments		$	38,726,858			$	9,395,389			$	101,793,329			($	7,458,879	)		$	18,084,699

Compensation Actually Paid		$	95,274,525			$	28,687,892			$	119,135,192			$	24,757,155			$	39,820,493

(5)	Compensation Actually Paid to PEO #2 (Mr. Tan) reflects the following adjustments from Total compensation reported in the Summary Compensation Table:


	2025		2024		2023		2022		2021
Total Reported in Summary Compensation Table (SCT)		—		—		—		—		$	11,166,016

Less, value of Stock Awards reported in SCT		—		—		—		—		($	8,999,65	)
Plus, Year-End value of Awards Granted in Fiscal Year that are Unvested and Outstanding		—		—		—		—		$	12,344,763
Plus, Change in Fair Value (from prior year-end to indicated year-end) of Prior Years awards that are Outstanding and Unvested		—		—		—		—		$	6,806,871
Plus, FMV of Awards Granted and Vested in the indicated Year		—		—		—		—		$	1,003,000
Plus, Change in Fair Value (from prior year-end to vesting date) of Prior Year awards that Vested this year		—		—		—		—		$	38,030,290
Less Prior Year Fair Value of Prior Year awards that Failed to vest this year		—		—		—		—		($	0	)

Total Adjustments		—		—		—		—		$	49,185,274

Compensation Actually Paid		—		—		—		—		$	60,351,290

(6)	The average Compensation Actually Paid to the non-PEO NEOs reflects the following adjustments from Total compensation reported in the Summary Compensation Table:


	2025			2024			2023			2022			2021
Total Reported in Summary Compensation Table (SCT)	$	15,806,397		$	5,477,021		$	5,291,144		$	10,293,930		$	5,188,515

Less, value of Stock Awards reported in SCT	($	14,592,540	)	($	4,440,047	)	($	4,105,718	)	($	9,032,300	)	($	3,999,937	)
Plus, Year-End value of Awards Granted in Fiscal Year that are Unvested and Outstanding	$	20,774,398		$	4,175,195		$	5,483,961		$	10,165,513		$	5,017,287
Plus, Change in Fair Value (from prior year-end to indicated year-end) of Prior Years awards that are Outstanding and Unvested	$	2,053,049		$	1,268,894		$	16,894,138		($	11,766,78	)	($	1,923,004	)
Plus, FMV of Awards Granted and Vested in the indicated Year	$	0		$	222,918		$	314,241		$	216,729		$	208,366
Plus, Change in Fair Value (from prior year-end to vesting date) of Prior Year awards that Vested this year	$	588,511		$	1,262,760		$	10,459,620		$	7,500,782		$	10,047,986
Less Prior Year Fair Value of Prior Year awards that Failed to vest this year	($	0	)	($	0	)	($	0	)	($	0	)	($	0	)

Total Adjustments	$	8,823,418		$	2,489,720		$	29,046,242		($	2,916,064	)	$	9,350,699

Compensation Actually Paid	$	24,629,815		$	7,966,742		$	34,337,386		$	7,377,865		$	14,539,214

(7)

Peer group TSR reflects the S&P 500 Information Technology Index performance as reflected in the Annual Report pursuant to Item 201(e) of Regulation

S-K.

For Cadence’s and the peer group’s TSR, each year reflects what the cumulative value of $100 would be, including reinvestment of dividends, if such amount were invested on January 2, 2021.

(8)

We identified

Non-GAAP

Operating Income Dollars as our company selected measure which is defined as operating income adjusted for amortization of acquired intangibles, stock-based compensation expense,

non-qualified

deferred compensation expenses or credits, restructuring charges or credits, acquisition- and integration-related costs, and special charges. A reconciliation of our

non-GAAP

to GAAP financial results is set forth in Appendix B to this proxy statement.

Company Selected Measure Name

Non-GAAP Operating Income

Named Executive Officers, Footnote

(1)	NEOs included in the above compensation columns reflect the following:


Year	PEO #1	PEO #2	Non-PEO NEOs
2025	Dr. Devgan	—	Messrs. Wall, Cunningham, Teng and Scannell
2024 2023	Dr. Devgan Dr. Devgan	— —	Messrs. Wall, Beckley, Cunningham, Teng and Scannell Messrs. Wall, Zaman, Cunningham and Teng
2022	Dr. Devgan	—	Messrs. Wall, Zaman, Cunningham and Teng
2021	Dr. Devgan	Mr. Tan	Messrs. Wall, Zaman, Teng and Beckley

Peer Group Issuers, Footnote

Peer group TSR reflects the S&P 500 Information Technology Index performance as reflected in the Annual Report pursuant to Item 201(e) of Regulation

S-K.

For Cadence’s and the peer group’s TSR, each year reflects what the cumulative value of $100 would be, including reinvestment of dividends, if such amount were invested on January 2, 2021.

Adjustment To PEO Compensation, Footnote

(4)	Compensation Actually Paid to PEO #1 (Dr. Devgan) reflects the following adjustments from Total compensation reported in the Summary Compensation Table:


	2025				2024				2023				2022				2021
Total Reported in Summary Compensation Table (SCT)		$	56,547,667			$	19,292,503			$	17,341,862			$	32,216,034			$	21,735,794

Less, value of Stock Awards reported in SCT		($	54,412,532	)		($	17,351,77	)		($	15,392,704	)		($	30,098,15	)		($	19,996,36	)
Plus, Year-End value of Awards Granted in Fiscal Year that are Unvested and Outstanding		$	79,730,095			$	15,440,701			$	20,512,907			$	33,730,111			$	20,926,797
Plus, Change in Fair Value (from prior year-end to indicated year-end) of Prior Years awards that are Outstanding and Unvested		$	9,473,706			$	6,094,969			$	65,834,172			($	31,069,49	)		($	4,318,614	)
Plus, FMV of Awards Granted and Vested in the indicated Year		$	0			$	1,326,066			$	1,733,185			$	962,229			$	557,207
Plus, Change in Fair Value (from prior year-end to vesting date) of Prior Year awards that Vested this year		$	3,935,589			$	3,885,430			$	29,105,769			$	19,016,429			$	20,915,668
Less Prior Year Fair Value of Prior Year awards that Failed to vest this year		($	0	)		($	0	)		($	0	)		($	0	)		($	0	)

Total Adjustments		$	38,726,858			$	9,395,389			$	101,793,329			($	7,458,879	)		$	18,084,699

Compensation Actually Paid		$	95,274,525			$	28,687,892			$	119,135,192			$	24,757,155			$	39,820,493

(5)	Compensation Actually Paid to PEO #2 (Mr. Tan) reflects the following adjustments from Total compensation reported in the Summary Compensation Table:


	2025		2024		2023		2022		2021
Total Reported in Summary Compensation Table (SCT)		—		—		—		—		$	11,166,016

Less, value of Stock Awards reported in SCT		—		—		—		—		($	8,999,65	)
Plus, Year-End value of Awards Granted in Fiscal Year that are Unvested and Outstanding		—		—		—		—		$	12,344,763
Plus, Change in Fair Value (from prior year-end to indicated year-end) of Prior Years awards that are Outstanding and Unvested		—		—		—		—		$	6,806,871
Plus, FMV of Awards Granted and Vested in the indicated Year		—		—		—		—		$	1,003,000
Plus, Change in Fair Value (from prior year-end to vesting date) of Prior Year awards that Vested this year		—		—		—		—		$	38,030,290
Less Prior Year Fair Value of Prior Year awards that Failed to vest this year		—		—		—		—		($	0	)

Total Adjustments		—		—		—		—		$	49,185,274

Compensation Actually Paid		—		—		—		—		$	60,351,290

Non-PEO NEO Average Total Compensation Amount

$ 15,806,397

$ 5,477,021

$ 5,291,144

$ 10,293,930

$ 5,188,515

Non-PEO NEO Average Compensation Actually Paid Amount

$ 24,629,815

7,966,742

34,337,386

7,377,865

14,539,214

Adjustment to Non-PEO NEO Compensation Footnote

(6)	The average Compensation Actually Paid to the non-PEO NEOs reflects the following adjustments from Total compensation reported in the Summary Compensation Table:


	2025			2024			2023			2022			2021
Total Reported in Summary Compensation Table (SCT)	$	15,806,397		$	5,477,021		$	5,291,144		$	10,293,930		$	5,188,515

Less, value of Stock Awards reported in SCT	($	14,592,540	)	($	4,440,047	)	($	4,105,718	)	($	9,032,300	)	($	3,999,937	)
Plus, Year-End value of Awards Granted in Fiscal Year that are Unvested and Outstanding	$	20,774,398		$	4,175,195		$	5,483,961		$	10,165,513		$	5,017,287
Plus, Change in Fair Value (from prior year-end to indicated year-end) of Prior Years awards that are Outstanding and Unvested	$	2,053,049		$	1,268,894		$	16,894,138		($	11,766,78	)	($	1,923,004	)
Plus, FMV of Awards Granted and Vested in the indicated Year	$	0		$	222,918		$	314,241		$	216,729		$	208,366
Plus, Change in Fair Value (from prior year-end to vesting date) of Prior Year awards that Vested this year	$	588,511		$	1,262,760		$	10,459,620		$	7,500,782		$	10,047,986
Less Prior Year Fair Value of Prior Year awards that Failed to vest this year	($	0	)	($	0	)	($	0	)	($	0	)	($	0	)

Total Adjustments	$	8,823,418		$	2,489,720		$	29,046,242		($	2,916,064	)	$	9,350,699

Compensation Actually Paid	$	24,629,815		$	7,966,742		$	34,337,386		$	7,377,865		$	14,539,214

Compensation Actually Paid vs. Total Shareholder Return

Compensation Actually Paid versus Total Shareholder Return

As indicated above, we believe there is a strong alignment between Compensation Actually Paid and our TSR as we have generally outperformed our peer group. Specifically, when our stock price has grown (in 2021, 2023, 2024, and 2025), the Compensation Actually Paid has been above our Summary Compensation Table values and when our stock price has decreased (2022) the Compensation Actually Paid has been below our Summary Compensation Table values (and lower than prior years). As noted above, the lower Compensation Actually Paid values in 2024 compared to 2023, are a result of several factors including lower price growth and fewer outstanding LTP awards included in the calculations. The higher Compensation Actually Paid values in 2023 compared to 2022 and 2025 compared to 2024 are a result of several factors including significant stock price growth and the use of options (prior to 2025) and periodic LTP grants in the program.

Compensation Actually Paid vs. Net Income

Compensation Actually Paid versus GAAP Net Income and

non-GAAP

Operating Income (Company Selected Metric)

As alluded to above, and compared to correlation with TSR, we see a weaker correlation between our financial and operational metrics and Compensation Actually Paid. In the past five years, our GAAP Net Income and

non-GAAP

Operating Income has grown; however, our Compensation Actually Paid has varied over that same period of time (higher values in 2021, 2023, and 2025 and lower values in 2022 and 2024). This underscores that our compensation program is materially tied to stock price performance and creates alignment with the stockholder experience.

Compensation Actually Paid vs. Company Selected Measure

Tabular List, Table

The following is a list of financial performance and

non-financial

performance measures, which in our assessment represent the most important measures used by Cadence to link Compensation Actually Paid to the NEOs for 2025:

Revenue

Stock Price Performance

Non-GAAP

Operating Income Dollars

Non-GAAP

Operating Income Margin

For additional details regarding these performance measures, please see the sections titled “Short-Term Cash Incentive Compensation under the Senior Executive Bonus Plan” and “Equity Incentive Compensation” in our “Compensation Discussion and Analysis” elsewhere in this proxy statement.

Total Shareholder Return Amount

$ 229

220

200

118

137

Peer Group Total Shareholder Return Amount

258

208

152

135

Net Income (Loss)

$ 1,108,888,000

$ 1,055,484,000

$ 1,041,144,000

$ 848,952,000

$ 695,955,000

Company Selected Measure Amount

2,361,000,000

1,974,360,000

1,717,212,000

1,436,357,000

1,110,755,000

Minimum Stock Price

5.00%

Maximum Stock Price

10.00%

Decreasing in Stock Price

70.00%

14.00%

Increase in Stock Price

10.00%

70.00%

Measure:: 1

Revenue

Measure:: 2

Stock Price Performance

Measure:: 3

Non-GAAP Measure Description

Non-GAAP Operating Income Dollars

We identified

Non-GAAP

Operating Income Dollars as our company selected measure which is defined as operating income adjusted for amortization of acquired intangibles, stock-based compensation expense,

non-qualified

deferred compensation expenses or credits, restructuring charges or credits, acquisition- and integration-related costs, and special charges. A reconciliation of our

non-GAAP

to GAAP financial results is set forth in Appendix B to this proxy statement.

Measure:: 4

Non-GAAP Operating Income Margin

Dr. Devgan [Member]

PEO Total Compensation Amount

$ 56,547,667

$ 19,292,503

$ 17,341,862

$ 32,216,034

$ 21,735,794

PEO Actually Paid Compensation Amount

$ 95,274,525

$ 28,687,892

$ 119,135,192

$ 24,757,155

$ 39,820,493

PEO Name

Dr. Devgan

Mr. Tan [Member]

PEO Total Compensation Amount

$ 11,166,016

PEO Actually Paid Compensation Amount

$ 60,351,290

PEO Name

Mr. Tan

PEO | Dr. Devgan [Member] | Equity Awards Adjustments

PEO | Dr. Devgan [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

$ 38,726,858

$ 9,395,389

$ 101,793,329

$ (7,458,879)

$ 18,084,699

PEO | Dr. Devgan [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

(54,412,532)

(1,735,177)

(15,392,704)

(3,009,815)

(1,999,636)

PEO | Dr. Devgan [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

79,730,095

15,440,701

20,512,907

33,730,111

20,926,797

PEO | Dr. Devgan [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

9,473,706

6,094,969

65,834,172

(3,106,949)

(4,318,614)

PEO | Dr. Devgan [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

1,326,066

1,733,185

962,229

557,207

PEO | Dr. Devgan [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year

3,935,589

3,885,430

29,105,769

19,016,429

20,915,668

PEO | Mr. Tan [Member] | Equity Awards Adjustments

PEO | Mr. Tan [Member] | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

49,185,274

PEO | Mr. Tan [Member] | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

(899,965)

PEO | Mr. Tan [Member] | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

12,344,763

PEO | Mr. Tan [Member] | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

6,806,871

PEO | Mr. Tan [Member] | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

1,003,000

PEO | Mr. Tan [Member] | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year

38,030,290

Non-PEO NEO | Equity Awards Adjustments

Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

8,823,418

2,489,720

29,046,242

(2,916,064)

9,350,699

Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

(14,592,540)

(4,440,047)

(4,105,718)

(9,032,300)

(3,999,937)

Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

20,774,398

4,175,195

5,483,961

10,165,513

5,017,287

Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year

2,053,049

1,268,894

16,894,138

(1,176,678)

(1,923,004)

Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

222,918

314,241

216,729

208,366

Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year

588,511

1,262,760

10,459,620

7,500,782

10,047,986